Finding 611726 (2022-001)

Significant Deficiency
Requirement
E
Questioned Costs
-
Year
2022
Accepted
2023-03-30
Audit: 24698
Organization: Aspirus, Inc. (WI)
Auditor: Wipfli LLP

AI Summary

  • Core Issue: Internal controls over eligibility for the HRSA COVID-19 program were ineffective, leading to incorrect claims.
  • Impacted Requirements: The program mandates confirming that patients are uninsured and not eligible for other coverage at the time of service.
  • Recommended Follow-Up: Management should implement a review process for verifying patient insurance coverage before submitting claims.

Finding Text

Finding 2022-001 Program Name/Assistance Listing Title: HRSA COVID-19 Claims Reimbursement for the Uninsured Program Federal Assistance Listing Number: 93.461 Federal Agency: U.S. Department of Health and Human Services Type of Finding: Significant Deficiency Compliance Requirement: Eligibility Questioned Costs: None Reported Condition: The Organization?s internal controls over compliance related to eligibility were not effective. Criteria: The program requires the Organization to confirm that the patient is uninsured and does not have coverage through an individual, or employer-sponsored plan, a federal healthcare program, or the Federal Employees Health Benefits Program at the time services were rendered, and no other payer will reimburse you for the COVID-19 related care. Context: During the audit, it was determined that 2 of the 40 patients selected for testing had adequate insurance at the time of their visit and therefore did not qualify for reimbursement under the program. Cause: Management oversight. Effect: The Organization?s internal controls around compliance were not effective. Recommendation: We recommend that management have a process in place to review insurance coverage on patients and the visits submitted under this program. View of Responsible Management will review the process that is currently in place to ensure accuracy in the eligibility Officials: calculations under this program.

Categories

Internal Control / Segregation of Duties Cash Management Eligibility Significant Deficiency

Other Findings in this Audit

  • 35284 2022-001
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.498 Provider Relief Fund $16.72M
93.461 Covid-19 Testing for the Uninsured $1.66M
93.697 Covid-19 Testing for Rural Health Clinics $741,921
21.027 Coronavirus State and Local Fiscal Recovery Funds $496,050
93.399 Cancer Control $373,216
93.155 Rural Health Research Centers $11,679
21.019 Coronavirus Relief Fund $5,445
93.889 National Bioterrorism Hospital Preparedness Program $2,815
93.395 Cancer Treatment Research $1,226